We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
151 hedge funds and large institutions have $1.09B invested in Madrigal Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 60 increasing their positions, 37 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
82% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 17
62% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 37
15% more call options, than puts
Call options by funds: $5.62M | Put options by funds: $4.91M
10% more funds holding
Funds holding: 137 → 151 (+14)
8.49% less ownership
Funds ownership: 76.17% → 67.69% (-8.5%)
23% less capital invested
Capital invested by funds: $1.43B → $1.09B (-$334M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
151
Holders Change
+14
Holders Change %
+10.22%
% of All Funds
2.63%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
31
Increased
60
Reduced
37
Closed
17
Calls
$5.62M
Puts
$4.91M
Net Calls
+$712K
Net Calls Change
-$3.95M
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$28.6M |
| 2 |
Citigroup
New York
|
+$19.3M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$11.6M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$11.3M |
| 5 |
LC
L1 Capital
Melbourne VIC 3000,
Australia
|
+$6.19M |
Top Sellers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$169M |
| 2 |
Morgan Stanley
New York
|
-$20M |
| 3 |
Two Sigma Investments
New York
|
-$13.3M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$12.3M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$9.65M |
